• The fusion transcript is a promising therapeutic target for head and neck cancer
  • With promising results from animal studies, the team is planning to soon undertake clinical trials in oral cancer patients
  • An FDA-approved deworming drug called pyrvinium pamoate can be a potential drug to treat such cancer